4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]morpholine, 97.0%, 25g

Ethyl 4-Bromobutyrate>97.0%(GC)100g

3-Chloro-1H-pyrazolo[4,3-c]pyridine-7-carbaldehyde, 95.0%, 250mg

2-Fluoro-4-(trifluoromethyl)nicotinic acid, 97%, 5g

3-(tert-Butyl)-4-hydroxybenzonitrile, 95.0%, 1g

1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLAN-1-YL)BENZENE, 98%, 250mg

(4S,4'S)-4,4'-Di-sec-butyl-1,1'-di-p-tolyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

2,9-Dichloro-4,7-diphenyl-1,10-phenanthroline, 95.0%, 5g

G2 Glycan>95.0%(HPLC)1mg

1,2-Dimethyl-4-(pentafluoroethyl)benzene, 98.0%, 5g

2-Amino-3-(4-bromo-1H-indol-3-yl)propanoic acid, 95.0%, 500mg

5-Aminobenzimidazole>98.0%(GC)5g

Methyl 3,5-difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 1g